Trial intelligence / Profile preview

Tempocol-ColoPulse vs Tempocol in Healthy Volunteers

NCT02291445Phase 2Completed

Sponsor
Maastricht University Medical Center+
Start
Mar 2015
Primary completion
Jul 2015
Countries
1
01

Overview

A Phase 2 trial of Tempocol-ColoPulse in irritable bowel syndrome (IBS), sponsored by Maastricht University Medical Center+. Started Mar 2015; status: completed.

02

Drugs

Tempocol-ColoPulse
03

Conditions

irritable bowel syndrome (IBS)

Beyond the preview

Go deeper on NCT02291445.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02291445.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call